VENTURE CAPITAL POST

Oklahoma, US-based anti-abortion craft store chain Hobby Lobby stirred controversy by investing $73 million in Pfizer, Bayer, and other companies that make abortive drugs and contraception.

After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.

Ben Venue Laboratories, a subsidiary of German Boehringer Ingelheim in the US, has engaged Bank of American Merill Lynch to advise it on a proposed sale of its sterile injectable drugs business.

Merck & Co. decided to cut its annual spending by USD2.5 billion and eliminate more than 10% of its global workers.

Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.

Pfizer invests in two plants in Ireland.

Pharmaceutical giant Pfizer Inc. (PFE) announced it had reached a settlement worth $2.15 billion with Teva Pharmaceutical Industries Ltd. (TEVA) and Sun Pharmaceutical Industries Ltd. (SUNP) after almost a decade of trials over Protonix sales in the United States.

Merck and Pfizer announce deal for the inclusion of ertugliflozin into current diabetes drug portfolios of the companies.

NicOx rise 4.6 percent as traders cite market talk of a potential takeover offer from Pfizer.

Bids, mergers, acquisitions and disposals involving European, U.S., Canadian and Asian companies.